The Pipeline

ACC 2014: The future of aortic aneurysm care—PEVAR in the cath lab


Vanessa Lo, Service Line Strategy Advisor

During one scientific session on the future of vascular services, experts highlighted the potential for percutaneous endovascular abdominal aneurysm repair (PEVAR) to impact aortic aneurysm care.

Recently, PEVAR has gained interest among vascular surgeons as the fully percutaneous procedure utilizes a suture closure device and requires only local or general anesthesia. With a less invasive approach, PEVAR results in lower morbidity, shorter procedure time, and reduced operating room (OR) costs. These advantages suggest the potential for the procedure to be performed in the cath lab with local anesthesia rather than in the OR.


Limited adoption—for now

Despite the benefits, adoption has been limited due to several factors. To date, a cost-effectiveness study has yet to be conducted to compare the procedural costs of PEVAR and EVAR. Additionally, surgeons often prefer EVAR as reimbursement is more favorable when there is a surgical cut down. 

Lastly, not all abdominal aortic aneurysm patients are eligible for PEVAR. For hospitals interested in adopting PEVAR, planners must collaborate with their vascular surgeons to develop robust criteria to ensure appropriate patient selection.

More from ACC 2014

Want more information on innovations highlighted at ACC? Check out the other posts in our series.

ACC 2014: Promising future for TAVR’s efficacy and LOS
ACC 2014: Renal denervation results call for further investigation
ACC 2014: Radial PCI learning curve may be overstated